The FDA is moving to phase out phenylephrine, the leading decongestant found in hundreds of over-the-counter medications, concluding that it doesn't actually relieve nasal congestion. This decision is expected to force drugmakers to remove or reformulate products, likely leading consumers to switch to alternatives.
For consumers, the change will likely mean switching to alternatives, including an older decongestant that was moved behind the pharmacy counter nearly 20 years ago.of your local pharmacy: U.S. officials are moving to phase out the leading decongestant found in hundreds of over-the-counter medicines, concluding that it doesn’t actually relieve nasal congestion.
The FDA decision was expected after federal advisers last year voted unanimously that oral phenylephrine medications haven't been shown to relieve congestion. Phenylephrine wasn’t always the top choice for cold and allergy products. Many were originally formulated with a different drug, pseudoephedrine.
Nasal steroids generally have to be used daily to be highly effective. For short-term relief, patients can try antihistamine sprays, such as Astepro, which are faster acting.Why doesn’t phenylephrine work when taken by mouth? When Hendeles and his colleagues first petitioned the FDA on phenylephrine, they suggested a higher dose might be effective. But subsequent studies showed that even doses 400% higher than those currently recommended don’t treat stuffiness.
FDA DECONGESTANT PHENYLEPHRINE MEDICATIONS ALLERGIES
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA to Phase Out Common DecongestantThe FDA is taking action against phenylephrine, a common decongestant found in many over-the-counter medications, due to concerns about its effectiveness.
Read more »
FDA to Phase Out Common DecongestantThe FDA is phasing out phenylephrine, a common decongestant found in many over-the-counter medications, due to concerns about its effectiveness.
Read more »
FDA to Phase Out Ineffective DecongestantThe U.S. Food and Drug Administration (FDA) is taking action to remove phenylephrine, a common decongestant, from over-the-counter medications due to its lack of effectiveness in relieving nasal congestion.
Read more »
FDA to Phase Out Common DecongestantThe FDA is taking action to remove phenylephrine, a common decongestant found in many over-the-counter medications, due to its lack of effectiveness in relieving nasal congestion.
Read more »
FDA to Phase Out Common Decongestant Found IneffectiveThe U.S. Food and Drug Administration is moving to phase out phenylephrine, the leading decongestant found in hundreds of over-the-counter medications, concluding that it doesn't actually relieve nasal congestion. This decision follows years of skepticism from experts and research indicating the drug's ineffectiveness. The FDA proposal is expected to force drugmakers to remove or reformulate products containing phenylephrine, prompting consumers to switch to alternative decongestants.
Read more »
US to Phase Out Common Decongestant Found IneffectiveThe U.S. Food and Drug Administration (FDA) is moving to phase out phenylephrine, the leading decongestant found in hundreds of over-the-counter medicines, after concluding it doesn't effectively relieve nasal congestion. This decision, based on expert review and multiple studies, is expected to force drugmakers to remove or reformulate products containing phenylephrine, prompting consumers to switch to alternatives.
Read more »